These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 29945301)

  • 1. Relationship and probabilistic stratification of Eczema Area and Severity Index and objective Scoring Atopic Dermatitis severity scores for atopic dermatitis.
    Hurault G; Schram ME; Roekevisch E; Spuls PI; Tanaka RJ
    Br J Dermatol; 2018 Oct; 179(4):1003-1005. PubMed ID: 29945301
    [No Abstract]   [Full Text] [Related]  

  • 2. Assessment of clinical signs of atopic dermatitis: a systematic review and recommendation.
    Schmitt J; Langan S; Deckert S; Svensson A; von Kobyletzki L; Thomas K; Spuls P;
    J Allergy Clin Immunol; 2013 Dec; 132(6):1337-47. PubMed ID: 24035157
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcome measures of disease severity in atopic eczema.
    Charman C; Williams H
    Arch Dermatol; 2000 Jun; 136(6):763-9. PubMed ID: 10871941
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Approach to the Assessment and Management of Adult Patients With Atopic Dermatitis: A Consensus Document. Section II: Tools for Assessing the Severity of Atopic Dermatitis.
    Gooderham MJ; Bissonnette R; Grewal P; Lansang P; Papp KA; Hong CH
    J Cutan Med Surg; 2018; 22(1_suppl):10S-16S. PubMed ID: 30439297
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Validity and reliability of Patient-Reported Outcomes Measurement Information System Global Health scale in adults with atopic dermatitis.
    Schwartzman G; Lei D; Yousaf M; Janmohamed SR; Vakharia PP; Chopra R; Chavda R; Gabriel S; Patel KR; Singam V; Kantor R; Hsu DY; Silverberg JI
    J Am Acad Dermatol; 2021 Sep; 85(3):636-644. PubMed ID: 33484762
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Texting atopic dermatitis patients to optimize learning and eczema area and severity index scores: A pilot randomized control trial.
    Singer HM; Levin LE; Morel KD; Garzon MC; Stockwell MS; Lauren CT
    Pediatr Dermatol; 2018 Jul; 35(4):453-457. PubMed ID: 29722071
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Severity strata for Eczema Area and Severity Index (EASI), modified EASI, Scoring Atopic Dermatitis (SCORAD), objective SCORAD, Atopic Dermatitis Severity Index and body surface area in adolescents and adults with atopic dermatitis.
    Chopra R; Vakharia PP; Sacotte R; Patel N; Immaneni S; White T; Kantor R; Hsu DY; Silverberg JI
    Br J Dermatol; 2017 Nov; 177(5):1316-1321. PubMed ID: 28485036
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Not Available].
    Lacour JP
    Ann Dermatol Venereol; 2020 Nov; 147(11S1):11S12-11S18. PubMed ID: 33250133
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessing the severity of atopic dermatitis in clinical trials and practice.
    Chopra R; Silverberg JI
    Clin Dermatol; 2018; 36(5):606-615. PubMed ID: 30217273
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Guidelines of care for the management of atopic dermatitis: section 1. Diagnosis and assessment of atopic dermatitis.
    Eichenfield LF; Tom WL; Chamlin SL; Feldman SR; Hanifin JM; Simpson EL; Berger TG; Bergman JN; Cohen DE; Cooper KD; Cordoro KM; Davis DM; Krol A; Margolis DJ; Paller AS; Schwarzenberger K; Silverman RA; Williams HC; Elmets CA; Block J; Harrod CG; Smith Begolka W; Sidbury R
    J Am Acad Dermatol; 2014 Feb; 70(2):338-51. PubMed ID: 24290431
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Validation of five patient-reported outcomes for atopic dermatitis severity in adults.
    Silverberg JI; Margolis DJ; Boguniewicz M; Fonacier L; Grayson MH; Ong PY; Fuxench ZC; Simpson EL
    Br J Dermatol; 2020 Jan; 182(1):104-111. PubMed ID: 30972740
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of Patient-Oriented Eczema Measure and Patient-Oriented Scoring Atopic Dermatitis vs Eczema Area and Severity Index and other measures of atopic dermatitis: A validation study.
    Silverberg JI; Lei D; Yousaf M; Janmohamed SR; Vakharia PP; Chopra R; Chavda R; Gabriel S; Patel KR; Singam V; Kantor R; Hsu DY
    Ann Allergy Asthma Immunol; 2020 Jul; 125(1):78-83. PubMed ID: 32199977
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Harmonising Outcome Measures for Eczema (HOME) statement to assess clinical signs of atopic eczema in trials.
    Schmitt J; Spuls PI; Thomas KS; Simpson E; Furue M; Deckert S; Dohil M; Apfelbacher C; Singh JA; Chalmers J; Williams HC;
    J Allergy Clin Immunol; 2014 Oct; 134(4):800-7. PubMed ID: 25282560
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reliability testing of the Six Area, Six Sign Atopic Dermatitis severity score.
    Charman CR; Venn AJ; Williams HC
    Br J Dermatol; 2002 Jun; 146(6):1057-60. PubMed ID: 12072077
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Measuring Atopic Dermatitis Disease Severity: The Potential for Electronic Tools to Benefit Clinical Care.
    Maintz L; Bieber T; Bissonnette R; Jack C
    J Allergy Clin Immunol Pract; 2021 Apr; 9(4):1473-1486.e2. PubMed ID: 33838840
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of anti-IgE (omalizumab/Xolair) in the management of severe recalcitrant paediatric atopic eczema (ADAPT): statistical analysis plan.
    Chen T; Chan S; Lack G; Cro S; Cornelius VR
    Trials; 2017 May; 18(1):231. PubMed ID: 28535776
    [TBL] [Abstract][Full Text] [Related]  

  • 17. What are the best outcome measurements for atopic eczema? A systematic review.
    Schmitt J; Langan S; Williams HC;
    J Allergy Clin Immunol; 2007 Dec; 120(6):1389-98. PubMed ID: 17910890
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Measuring atopic eczema severity visually: which variables are most important to patients?
    Charman CR; Venn AJ; Williams H
    Arch Dermatol; 2005 Sep; 141(9):1146-51; discussion 1151. PubMed ID: 16172312
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pediatric atopic eczema: the impact of an educational intervention.
    Grillo M; Gassner L; Marshman G; Dunn S; Hudson P
    Pediatr Dermatol; 2006; 23(5):428-36. PubMed ID: 17014636
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Placebo responses in randomized controlled trials for systemic therapy in atopic dermatitis: A systematic review and meta-analysis.
    Lee HH; Patel KR; Rastogi S; Singam V; Vakharia PP; Chopra R; Silverberg JI
    J Am Acad Dermatol; 2020 Jan; 82(1):62-71. PubMed ID: 31202874
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.